|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
389,580,000 |
Market
Cap: |
46.27(B) |
Last
Volume: |
6,065,509 |
Avg
Vol: |
1,917,222 |
52
Week Range: |
$75.49 - $140.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 487 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
213,540 |
274,778 |
302,534 |
572,658 |
Total Sell Value |
$28,796,122 |
$36,325,434 |
$39,473,632 |
$69,793,485 |
Total People Sold |
7 |
9 |
14 |
15 |
Total Sell Transactions |
14 |
24 |
45 |
79 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Collins Richard Alexander |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
787 |
787 |
|
- |
|
Kahn Barbara |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
787 |
787 |
|
- |
|
Heller Bridgette P |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
787 |
3,823 |
|
- |
|
Topol Eric |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
833 |
833 |
|
- |
|
Altman Steven R |
Director |
|
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
806 |
806 |
|
- |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-05-22 |
4 |
AS |
$396.74 |
$607,409 |
D/D |
(1,531) |
77,470 |
|
-4% |
|
Augustinos Nicholas |
Director |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,230 |
17,592 |
|
- |
|
Augustinos Nicholas |
Director |
|
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,230) |
0 |
|
- |
|
Foletta Mark G |
Director |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,055 |
16,202 |
|
- |
|
Foletta Mark G |
Director |
|
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,055) |
0 |
|
- |
|
Skyler Jay S |
Director |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,729 |
33,146 |
|
- |
|
Skyler Jay S |
Director |
|
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,729) |
0 |
|
- |
|
Collins Richard Alexander |
Director |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,613 |
7,917 |
|
- |
|
Collins Richard Alexander |
Director |
|
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,613) |
0 |
|
- |
|
Kahn Barbara |
Director |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,613 |
13,879 |
|
- |
|
Kahn Barbara |
Director |
|
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,613) |
0 |
|
- |
|
Topol Eric |
Director |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,766 |
91,014 |
|
- |
|
Topol Eric |
Director |
|
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,766) |
0 |
|
- |
|
Altman Steven R |
Director |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,676 |
48,980 |
|
- |
|
Altman Steven R |
Director |
|
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,676) |
0 |
|
- |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2020-05-11 |
4 |
AS |
$404.05 |
$202,025 |
D/D |
(500) |
29,676 |
|
-7% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-05-11 |
4 |
AS |
$404.05 |
$161,620 |
D/D |
(400) |
24,715 |
|
-7% |
|
Selvaraj Shelly Ramasamy |
SVP Information Technology |
|
2020-05-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
279 |
25,115 |
|
- |
|
Sayer Kevin R |
President, CEO and Chairman |
|
2020-05-04 |
4 |
AS |
$340.80 |
$2,067,761 |
D/D |
(6,000) |
164,542 |
|
12% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2020-04-23 |
4 |
AS |
$318.57 |
$487,731 |
D/D |
(1,531) |
79,001 |
|
39% |
|
1713 Records found
|
|
Page 19 of 69 |
|
|